Publication date: Jul 07, 2025
“Meta-analysis of 19 studies has confirmed that elevated levels of CRP are strongly associated with poorer outcomes in patients with melanoma. China: A new meta-analysis published in Annals of Medicine has identified elevated C-reactive protein (CRP) levels as a strong indicator of poor outcomes in patients with melanoma. “These associations remained consistent across various patient subgroups, highlighting the potential of CRP as a reliable and clinically useful prognostic marker in the management of melanoma. “Melanoma, a severe form of skin cancer, often presents challenges in predicting disease progression and survival outcomes. Prognostic value of C-reactive protein in patients with melanoma: a meta-analysis. While CRPa marker of systemic inflammationhas been examined in previous studies for its prognostic role, the results have varied considerably. A total of 19 studies involving 4,634 patients were included.
| Concepts | Keywords |
|---|---|
| Cancer | Analysis |
| China | Clinical |
| Databases | Confirmed |
| Reliable | Crp |
| Death | |
| Elevated | |
| Marker | |
| Melanoma | |
| Meta | |
| Outcomes | |
| Patient | |
| Patients | |
| Prognostic | |
| Progression | |
| Risk |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Death |
| disease | MESH | Disease Progression |
| disease | MESH | Melanoma |
| pathway | KEGG | Melanoma |
| disease | MESH | skin cancer |
| drug | DRUGBANK | Tropicamide |